BioNTech and Pfizer are ramping up production of their coronavirus vaccine in time to deliver it to the EU. Pfizer has modified production processes at its plant in the Belgian city of Poors, and BioNTech will start producing the drug at its Marburg site in February. The companies intend to produce 2 billion doses of the vaccine in 2021.